Brief: Aclaris Therapeutics Reports Q1 2023 Financial Results And Provides A Corporate Update

Aclaris Therapeutics

08/05/2023 15:42

May 8 (Reuters) - Aclaris Therapeutics Inc  ACRS.O :
    * ACLARIS THERAPEUTICS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS AND PROVIDES A CORPORATE UPDATE
    * ACLARIS THERAPEUTICS - CONTINUES TO EXPECT CASH, CASH
EQUIVALENTS, MARKETABLE SECURITIES AS OF MARCH 31,  TO BE
SUFFICIENT TO FUND OPERATIONS THROUGH END OF 2025
    * QTRLY NET LOSS PER SHARE, BASIC AND DILUTED $0.42
    * Q1 EARNINGS PER SHARE VIEW $-0.44, REVENUE VIEW $1.7
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX6bD1j3 
Further company coverage:  ACRS.O 

 ((Reuters.Briefs@thomsonreuters.com;))